With this background, and to further validate AAV-mediated hepatic IRA expression as a potential gene therapy tool for decreasing hyperglycemia in insulin-resistant states, we hypothesized that this gene therapy approach could also work in a mouse model of diet-induced obesity. Here, INS is linked to Hyperglycemia.